In vitro anti-cancer effect of marmesin by suppression of PI3K/Akt pathway in esophagus cancer cells
ConclusionsMarmesin exerted anti-cancer activity in EC cells by inhibiting the PI3K/Akt pathway.
Source: Esophagus - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Esophagus Cancer | Gastroenterology | Study